87 results
424B5
WVE
Wave Life Sciences Ltd.
8 Dec 23
Prospectus supplement for primary offering
6:06am
on by, any other person. The DFSA has no responsibility for reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not
S … -37
approved this prospectus supplement nor taken steps to verify the information set forth herein and has no responsibility for this document
8-K
EX-1.1
WVE
Wave Life Sciences Ltd.
7 Dec 23
Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares
9:26pm
or any other party, (c) no Underwriter has assumed or will assume an advisory or fiduciary responsibility in favor of the Company with respect
424B5
h3d0b5 q2
6 Dec 23
Prospectus supplement for primary offering
4:13pm
8-K
ldwvv
26 Sep 22
Departure of Directors or Certain Officers
4:15pm
8-K
EX-1.1
o96dlsg
14 Jun 22
Wave Life Sciences Announces Pricing of $70.0 Million Underwritten Offering
9:32am
424B5
az2wd45rnfk0u
14 Jun 22
Prospectus supplement for primary offering
9:24am